The book is a collection of 39 articles which have been published in Delhi/ Chandigarh edition of the Financial World. These articles have been authored by Dr. Angrish alone or along with his students. To come out with different themes as presented in the book, these articles have been clubbed under different headings namely External Sector comprising Import and Export, Finance, Entrepreneurship, Intellectual Property, Pharma 2.0, Environmental, Social and Governance (ESG), Accessibility and Affordability, Strategic Management, and Human Capital. ... These themes essentially represent the pharmaceutical industry as India is a major exporter of pharmaceutical products and is known as the Pharmacy of the World. At the same time, the country relies on imports of Key Starting Materials, Drug Intermediates, and Active Pharmaceutical Ingredients (APIs) so the discussion on ‘External Sector’ is essential. Indian pharmaceutical sector is dominated by family-owned businesses so entrepreneurship has been included as a key element. Finance is the life blood of any business entity so the role of FDI, private equity players, impact of inflation on drug prices, impact of exchange rate fluctuations due to volatility in currency markets, role of promoter holding, segment reporting by pharma companies, forex rate risk, investment in R&D, spin-off by pharmaceutical companies has been included. Intellectual Property and Intellectual Capital has become a key determinant post-2005 Product Patent regime so the discussion of IPR is an integral component of any IP-intensive domain including pharmaceuticals. Pharma 2.0 covers the role of biopharmaceuticals and the role of Artificial Intelligence. ESG has become a major concern for pharmaceutical sector in addition to the concern for Accessibility and Affordability. Strategic Management covers important issues such as Competitive Intelligence, Risk Management, Board Characteristics, Divestiture and Diversification of the industry. Finally, Human Capital component has been incorporated as it is the key determinant of any knowledge-intensive industry. Because of Human Capital, Indian pharmaceutical industry attained the status of the Pharmacy of the World
Dr. Anil Kumar Angrish is Ph.D. from University Business School, Panjab University, Chandigarh. He has teaching and research experience of almost 25 years. He has more than 130 publications (research papers, book chapters, and articles) to his credit as author/co-author. His publications have appeared in Management Accountant & Research Bulletin (journals of the Institute of Cost Accountants of India), Chartered Secretary (journal of the Institute of Company Secretaries of India), Empirical Economic Letters, CLIO, Business Line, Financial World, University News (journal of Association of Indian Universities), Fortune India, among others. Book chapters have been published in the publications of Entrepreneurship Development Institute of India, Springer Nature (Singapore), Weser, Asia-Pacific Business Series of World Scientific Publishing Company, Bloomsbury India, Rubicon Publications, IGI Global, Emerald Publishing among others. Dr. Angrish has acted as a reviewer for publications of IGI Global, Sage, and Emerald Publishing. Dr. Angrish has guided more than 200 post-graduate students for their major research projects. He has served as a member of various institutional committees and outside bodies. His inputs have been acknowledged by the Competition Commission of India (CCI) in a verdict on Voluntary Licensing.